Mr. Arato was diagnosed with pancreatic cancer and treated by oncologist Dr. Avedon and other physicians. Following surgery, his physicians recommended chemotherapy and conveyed an optimistic outlook, using terms such as treatment with a "curative intent" and statements indicating there was "no evidence of disease," while not volunteering numerical statistics on median survival or likely life expectancy for pancreatic cancer. The Aratos contended they repeatedly sought information about prognosis and survivability, and that the physicians neither disclosed available statistical life-expectancy data nor made clear that the realistic goal of therapy was palliative rather than curative. Mr. Arato continued to make significant business and financial commitments he allegedly would have avoided had he been given statistical information about his short life expectancy. He died within a relatively brief period after diagnosis. His survivors sued, alleging lack of informed consent and related negligence theories premised on the nondisclosure of statistical life-expectancy information and misleadingly optimistic statements. A jury instruction informed the jury that physicians had a duty to disclose statistical life expectancy. The verdict favored plaintiffs, and the case reached the California Supreme Court on the question whether such a categorical duty exists.
Do physicians have a legal duty, as a matter of informed consent, to disclose statistical life-expectancy or survival-rate data to a patient, irrespective of patient inquiry or case-specific circumstances?
Under Cobbs v. Grant, a physician must disclose all information material to a reasonable patient's decision to accept or reject a proposed treatment, including the nature of the procedure, its risks, benefits, alternatives, and the likely consequences of no treatment. The materiality standard is patient-centered, not defined by professional custom, though expert testimony may inform what risks exist, their likelihood, and accepted medical understandings. Physicians must not misrepresent or make false assurances and must answer a patient's specific questions truthfully and fully. However, there is no per se duty to volunteer numerical life-expectancy or survival-rate statistics; whether and how prognosis is discussed depends on materiality in the particular circumstances.
No. The California Supreme Court held there is no categorical legal duty requiring physicians to disclose statistical life-expectancy or survival-rate data. It was error to instruct the jury that such disclosure was required as a matter of law. The Court reversed and remanded for further proceedings under proper informed-consent principles.
The Court reaffirmed Cobbs's patient-based materiality standard, emphasizing that informed consent is meant to facilitate a patient's decision about medical treatment—not to impose a boundless obligation to volunteer all potentially relevant data. Numerical life-expectancy figures and population survival rates are inherently probabilistic, derived from heterogeneous cohorts, and often poorly tailored to the particulars of an individual patient's disease stage, comorbidities, treatment response, and emerging therapies. Mandating disclosure of such statistics in every case risks misleading patients, undermining clinical judgment, and overwhelming the decisional process with numbers of uncertain individual applicability. While prognosis can be material, the Court drew an important distinction between qualitative disclosure and numerical mandates. Physicians must communicate the nature of the disease and the therapeutic intent—e.g., whether a proposed intervention is palliative rather than curative—and may be obligated to discuss prognosis to the extent it bears on a reasonable patient's treatment choice. They must also refrain from false assurances or misleading optimism and must answer direct patient questions about prognosis candidly. However, the Court rejected a rule compelling physicians to recite statistical life-expectancy data regardless of patient inquiry or clinical context. The Court also clarified evidentiary and instructional points. Although professional custom does not define the legal standard (which is patient-oriented), expert testimony is relevant to explain risks, benefits, the state of medical knowledge, and how a reasonable physician would convey information. The improper jury instruction that effectively transformed statistical disclosure into a legal requirement distorted the Cobbs framework and warranted reversal. Finally, the Court noted that the duty of informed consent is aimed at medical decision-making; it does not expand to a general obligation to guide a patient's collateral personal or financial planning by volunteering population statistics, even if such information would be useful for those nonmedical decisions.
Arato refines the scope of informed consent in California. It confirms that materiality remains the touchstone, but declines to impose a per se duty to disclose numerical life-expectancy or survival statistics. The case is frequently taught alongside Cobbs v. Grant to illustrate the balance between patient autonomy and practical clinical communication, the limits on mandatory disclosure, the importance of accurate, non-misleading qualitative discussions about prognosis and therapeutic goals, and the obligation to respond truthfully to patient-specific inquiries. It also provides guidance on proper jury instructions and the role of expert testimony in informed-consent cases.
Arato v. Avedon is a cornerstone of California informed-consent law. It preserves patient autonomy by requiring disclosure of information material to treatment decisions and truthful answers to patient inquiries, while rejecting a rigid, across-the-board obligation to present numerical life-expectancy and survival-rate statistics that may be misleading or inapplicable to the individual.